What is Catalyst Pharmaceutical's debt-to-assets?

Catalyst Pharmaceutical (CPRX) reported debt-to-assets of 0× in Q1 2026.

How has Catalyst Pharmaceutical's debt-to-assets changed year-over-year?

Catalyst Pharmaceutical's debt-to-assets decreased by 32.4% year-over-year, from 0× to 0×.

What is the long-term trend for Catalyst Pharmaceutical's debt-to-assets?

Over 5 years (2020 to 2025), Catalyst Pharmaceutical's debt-to-assets has grown at a 90.4% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Catalyst Pharmaceutical CPRX Debt-to-assets

Debt-to-assets at other companies

PTC TherapeuticsPTCT

0.1×0.0×

Edgewise Therapeutics, Inc.EWTX

0×0.0×

Acadia PharmaceuticalsACAD

0×0.0×

Dyne Therapeutics, Inc.DYN

0.2×+0.1×

Scholar RockSRRK

0.4×+0.2×

Amneal Pharmaceuticals, Inc.AMRX

0.7×+0.1×

Other financials

Income statement

See full

Revenue$149.4M+5.6%

Gross profit$134.9M+9.2%

Operating income$73.2M+15.6%

Net income$63.7M+12.3%

EPS (diluted)$0.50+11.1%

Balance sheet

See full

Cash & equivalents$755.9M+30.2%

Total debt$2.7M-13.3%

Total equity$1.0B+27.5%

Total assets$1.1B+26.3%

Cash flow

See full

Operating cash flow$59.6M-0.8%

CapEx$27.0K—

Free cash flow$59.6M-0.8%

Valuation

See full

Market cap$3.84B+2.7%

Profitability

See full

Gross margin86%-0.2pp

Operating margin44.8%+1.6pp

Net margin37.1%+0.2pp

FCF margin34.9%-15.2pp

Returns & leverage

See full

Return on equity24.5%-4.6pp

Debt / equity0×0.0×

Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Catalyst Pharmaceutical's debt-to-assets?: Catalyst Pharmaceutical (CPRX) reported debt-to-assets of 0× in Q1 2026.
How has Catalyst Pharmaceutical's debt-to-assets changed year-over-year?: Catalyst Pharmaceutical's debt-to-assets decreased by 32.4% year-over-year, from 0× to 0×.
What is the long-term trend for Catalyst Pharmaceutical's debt-to-assets?: Over 5 years (2020 to 2025), Catalyst Pharmaceutical's debt-to-assets has grown at a 90.4% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.